Evidence map›Paper›PMID 40830161›Full record

ArticleScientific reports2025

Lung adenocarcinoma subtype classification based on contrastive learning model with multimodal integration.

Changmiao Wang, Lijian Liu, Chenchen Fan, Yongquan Zhang, Zhijun Mai, Li Li, Zhou Liu, Yuan Tian, Jiahang Hu, Ahmed Elazab

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Changmiao WangShenzhen Research Institute of Big Data, Shenzhen, China.
Lijian LiuNational Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Cancer, Cancer Hospital and Shenzhen Hospital, Shenzhen, China.
Chenchen FanZhejiang University of Finance and Economics, Hangzhou, China.
Yongquan ZhangZhejiang University of Finance and Economics, Hangzhou, China. zyq@zufe.edu.cn.
Zhijun MaiNational Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Cancer, Cancer Hospital and Shenzhen Hospital, Shenzhen, China.
Li LiNational Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Cancer, Cancer Hospital and Shenzhen Hospital, Shenzhen, China.
Zhou LiuNational Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Cancer, Cancer Hospital and Shenzhen Hospital, Shenzhen, China. zhou_liu8891@yeah.net.
Yuan TianThe Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen, China.
Jiahang HuHongqi Hospital Affiliated to Mudanjiang Medical University, Mudanjiang, China.
Ahmed ElazabSchool of Biomedical Engineering, Shenzhen University, Shenzhen, China.

Funding

GuangDong Basic and Applied Basic Research Foundation 2022A1515110570Innovation Teams of Youth Innovation in Science and Technology of High Education Institutions of Shandong Province 2021KJ088Scientific research project of Heilongjiang Provincial Institutions of higher Learning in 2022 2022-KYYWF-0669Shenzhen High-level Hospital Construction Fund, Shenzhen Clinical Research Center for Cancer [2021] 287Shenzhen Science and Technology Program KCXFZ20201221173008022Zhejiang Provincial Philosophy and Social Sciences Planning Project-Major Project 40023SYS12ZD
6 · The paper itself

Abstract

Accurately identifying the stages of lung adenocarcinoma is essential for selecting the most appropriate treatment plans. Nonetheless, this task is complicated due to challenges such as integrating diverse data, similarities among subtypes, and the need to capture contextual features, making precise differentiation difficult. We address these challenges and propose a multimodal deep neural network that integrates computed tomography (CT) images, annotated lesion bounding boxes, and electronic health records. Our model first combines bounding boxes with precise lesion location data and CT scans, generating a richer semantic representation through feature extraction from regions of interest to enhance localization accuracy using a vision transformer module. Beyond imaging data, the model also incorporates clinical information encoded using a fully connected encoder. Features extracted from both CT and clinical data are optimized for cosine similarity using a contrastive language-image pre-training module, ensuring they are cohesively integrated. In addition, we introduce an attention-based feature fusion module that harmonizes these features into a unified representation to fuse features from different modalities further. This integrated feature set is then fed into a classifier that effectively distinguishes among the three types of adenocarcinomas. Finally, we employ focal loss to mitigate the effects of unbalanced classes and contrastive learning loss to enhance feature representation and improve the model's performance. Our experiments on public and proprietary datasets demonstrate the efficiency of our model, achieving a superior validation accuracy of 81.42% and an area under the curve of 0.9120. These results significantly outperform recent multimodal classification approaches. The code is available at https://github.com/fancccc/LungCancerDC .

Indexed as

Adenocarcinoma of LungLung NeoplasmsDeep LearningHumansNeural Networks, ComputerTomography, X-Ray ComputedClinical InformationLung AdenocarcinomaMultimodal Learning

Identifiers

PMID40830161
PMCPMC12365151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.